# AstraZeneca Pharmaceuticals, LP - Inspection Records

Source: https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/ebec0358-60f4-4d3d-88a0-f03f946518ea

> Inspection records and compliance data for AstraZeneca Pharmaceuticals, LP in Newark, Delaware. Access full analysis and detailed observations.

---

## Details

- Name: AstraZeneca Pharmaceuticals, LP
- FEI Number: 2517100
- City: Newark
- State: Delaware
- Country Name: United States
- Address Line 1: 587 Old Baltimore Pike
- Zip Code: 19702
- Business Operations: PACK

## Related Documents

- [FDA Inspection 1211584 - AstraZeneca Pharmaceuticals, LP - 2023-07-19](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/3c06a69b-bae4-4442-8515-ad030865c29e) — classification: No Action Indicated (NAI), source: FDA, date: July 19, 2023
- [FDA Inspection 1022686 - AstraZeneca Pharmaceuticals, LP - 2017-08-24](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f2212a7e-f3ac-42a5-ad63-1ca1b64cf950) — classification: No Action Indicated (NAI), source: FDA, date: August 24, 2017
- [FDA Inspection 1022686 - AstraZeneca Pharmaceuticals, LP - 2017-08-24](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/6504f213-03f2-4da2-9d08-6b2de9882202) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 24, 2017
- [FDA Inspection 895233 - AstraZeneca Pharmaceuticals, LP - 2014-08-27](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/85d228df-13a6-44d7-8489-95ab6bab3f22) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 27, 2014
- [FDA Inspection 788561 - AstraZeneca Pharmaceuticals, LP - 2011-11-28](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/52f8236e-921e-485d-91d3-9461b11717a5) — classification: No Action Indicated (NAI), source: FDA, date: November 28, 2011
- [FDA Inspection 737328 - AstraZeneca Pharmaceuticals, LP - 2011-07-05](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/27f18c30-3fa6-4a56-bf7e-6f3ac0c77d36) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 5, 2011
- [FDA Inspection 611523 - AstraZeneca Pharmaceuticals, LP - 2009-09-10](https://www.globalkeysolutions.net/records/fda_inspections/astrazeneca-pharmaceuticals-lp/fe79131e-e500-4b4f-a1d0-9e42f88f4096) — classification: No Action Indicated (NAI), source: FDA, date: September 10, 2009

## Related Companies

- [Combe Laboratories, Inc.](https://www.globalkeysolutions.net/companies/combe-laboratories-inc/165d44db-fdc0-4975-af22-35ec39c2735d)
- [Orion Corporation, Orion Pharma](https://www.globalkeysolutions.net/companies/orion-corporation-orion-pharma/bc21b600-e8f7-4570-9285-d3c41399fd82)
- [Penn Pharmaceutical Services Limited](https://www.globalkeysolutions.net/companies/penn-pharmaceutical-services-limited/0568bf3c-6deb-4f8f-9174-a7ff34c80343)
- [Haleon US Holdings LLC](https://www.globalkeysolutions.net/companies/haleon-us-holdings-llc/03c10541-23fe-4547-ae02-c47669f35343)
- [Haupt Pharma Wuelfing GmbH](https://www.globalkeysolutions.net/companies/haupt-pharma-wuelfing-gmbh/34339ef4-fb2f-4297-ae5d-191a6adb86b0)
- [Delpharm Huningue S.A.S.](https://www.globalkeysolutions.net/companies/delpharm-huningue-sas/abe67002-072d-48fc-8ace-21b8021482f7)
- [Orion Corporation, Orion Pharma](https://www.globalkeysolutions.net/companies/orion-corporation-orion-pharma/afdfe2db-9213-4d8d-84c3-4627195bb4c7)
- [GlaxoSmithKline LLC](https://www.globalkeysolutions.net/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996)
- [S.s.s. Company (international)](https://www.globalkeysolutions.net/companies/sss-company-international/f322f704-186a-434c-83d2-9468fed1ae6e)
- [NORTON (WATERFORD) LIMITED](https://www.globalkeysolutions.net/companies/norton-waterford-limited/776bb20e-6234-4ca9-94ef-034d468a479a)